ABIVAX Société Anonyme (EPA:ABVX)
France flag France · Delayed Price · Currency is EUR
77.95
-1.00 (-1.27%)
Oct 19, 2026, 5:35 PM CET

ABIVAX Société Anonyme Revenue

ABIVAX Société Anonyme had revenue of 1.20M EUR in the quarter ending June 30, 2026, with 9.88% growth. This brings the company's total for the last twelve months to 5.03M, down -34.88% year-over-year. In the year 2025, ABIVAX Société Anonyme had annual revenue of 4.57M, down -63.29%. That makes ABIVAX Société Anonyme the 39,802nd largest company in the world by revenue and 521st in France.

Revenue (ttm)
5.03M
Revenue Growth
-34.88%
P/S Ratio
1,455.75
Revenue / Employee
47.63K
Employees
98
Market Cap
6.80B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 20254.57M-7.88M-63.29%
Dec 31, 202412.45M7.83M169.40%
Dec 31, 20234.62M38.00K0.83%
Dec 31, 20224.58M-7.38M-61.68%
Dec 31, 202111.96M--
Dec 31, 2020---
Dec 31, 2019---
Dec 31, 2018---
Dec 31, 2016151.00K-77.00K-33.77%
Dec 31, 2015228.00K--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.

Related Stocks

Company NameRevenue
Valneva SE142.94M
Genfit59.49M
Cellectis55.86M
MedinCell24.28M
Nanobiotix11.51M
Innate Pharma9.81M
Transgene5.62M
Valerio Therapeutics Société anonyme5.55M
Revenue Rankings